HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$4.06
Day range
$3.99 - $4.19
Year range
$3.62 - $9.18
Market cap
29.73M USD
Avg Volume
37.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.63M | 169.60% |
Net income | -16.56M | 23.56% |
Net profit margin | — | — |
Earnings per share | -2.00 | 33.33% |
EBITDA | -17.38M | 25.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 114.36M | -36.39% |
Total assets | 125.26M | -37.10% |
Total liabilities | 22.19M | -26.05% |
Total equity | 103.07M | — |
Shares outstanding | 7.31M | — |
Price to book | 0.29 | — |
Return on assets | -32.65% | — |
Return on capital | -35.22% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -16.56M | 23.56% |
Cash from operations | -17.19M | 24.81% |
Cash from investing | 13.74M | -32.66% |
Cash from financing | -1.30M | — |
Net change in cash | -4.75M | -92.89% |
Free cash flow | -15.05M | -3.40% |
About
Founded
2015
Headquarters
Website
Employees
55
